B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

DYRK2

MOLECULAR TARGET

dual specificity tyrosine phosphorylation regulated kinase 2

UniProt: Q92630NCBI Gene: 844534 compounds

DYRK2 (dual specificity tyrosine phosphorylation regulated kinase 2) is targeted by 34 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting DYRK2

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1erlotinib5.55256
2epigalocatechin gallate5.40220
3seliciclib4.91135
4foretinib4.3476
5ruxolitinib4.2368
6pi 1034.1764
7silmitasertib3.7843
8abemaciclib3.6638
9canertinib3.5333
106bio3.5032
11bms 3870323.4731
12at 75193.3327
13dovitinib3.0921
14at 92833.0921
15lestaurtinib3.0420
16r 4062.8316
17Harmine Alkaloid isolated from seeds of PEGANUM HARMALA; ZYGOPHYLLACEAE. It is identical to banisterine, or telepathine, from Banisteria caapi and is2.7715
18plx 47202.7114
19bms 3455412.7114
20kw 24492.6413
21ast 4872.5612
22berzosertib2.309
23su 0148132.208
24leucettamine b2.208
25tg100 1152.087
26zemirciclib2.087
27harmol2.087
28demethylbellidifolin1.956
29lorecivivint1.795
30egcg0.691
31Afatinib0.691
32Crizotinib0.691
33pictilisib0.691
34sp6001250.691

About DYRK2 as a Drug Target

DYRK2 (dual specificity tyrosine phosphorylation regulated kinase 2) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 34 compounds with documented DYRK2 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

DYRK2 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.